Gene, Cell and Tissue

Published by: Kowsar

Association Between Val34Leu Polymorphism and Risk of Umbilical Cord Bleeding in Severe Congenital Coagulation Factor XIII Deficiency in Southeast of Iran

Majid Naderi 1 , Akbar Dorgalaleh 2 , Shadi Tabibian 2 , Peyman Eshghi 3 , Taregh Bamedi 1 and Shaban Alizadeh 2 , *
Authors Information
1 Genetic Researcher Center in Non-Communicable Disease, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Department of Hematology, Allied Medical School, Tehran University of Medical Sciences, Tehran, IR Iran
3 Pediatric Congenital Hematologic Disorders Research Center of Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • Gene, Cell and Tissue: April 01, 2014, 1 (1); e18360
  • Published Online: March 12, 2014
  • Article Type: Research Article
  • Received: January 4, 2014
  • Revised: February 16, 2014
  • Accepted: February 19, 2014
  • DOI: 10.17795/gct-18360

To Cite: Naderi M, Dorgalaleh A, Tabibian S, Eshghi P, Bamedi T, et al. Association Between Val34Leu Polymorphism and Risk of Umbilical Cord Bleeding in Severe Congenital Coagulation Factor XIII Deficiency in Southeast of Iran, Gene Cell Tissue. 2014 ; 1(1):e18360. doi: 10.17795/gct-18360.

Copyright © 2014, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Naderi MMD. Current understanding in diagnosis and management of factor XIII deficiency. Iran J Pediatr Hematol Oncol. 2013; 3(4): 164-78
  • 2. Naderi M, Imani M, Eshghi P, Dorgalaleh A, Tabibian S, Alizadeh S, et al. Factor XIII deficiency in Sistan and Baluchistan province. Sci J Blood Transfus Organ. 2013; 10(3): 282-8
  • 3. Naderi M, Dorgalaleh A, Alizadeh S, Kazemi A, Tabibian S, Younesi MR. Assessment of relationship between CNS bleeding in factor XIII deficiency and Thrombin-Activatable Fibrinolysis Inhibitor polymorphism. Arak Med Univ J. 2013; 16(7)
  • 4. Naderi M, Dorgalaleh A, Alizadeh S, Tabibian S, Bamedi T, Karimi M. Molecular Analysis Of The Largest Group Of Patients With Factor XIII Deficiency In Southeast Of Iran. Blood. 2013; 122(21): 4780
  • 5. Naderi M, Dorgalaleh A, Alizadeh S, Kashani Khatib Z, Tabibian S, Kazemi A, et al. Polymorphism of thrombin-activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency. Haemophilia. 2014; 20(1)-92[DOI][PubMed]
  • 6. Catto AJ, Kohler HP, Bannan S, Stickland M, Carter A, Grant PJ. Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage. Stroke. 1998; 29(4): 813-6[PubMed]
  • 7. Anwar R, Minford A, Gallivan L, Trinh CH, Markham AF. Delayed umbilical bleeding--a presenting feature for factor XIII deficiency: clinical features, genetics, and management. Pediatrics. 2002; 109(2)[PubMed]
  • 8. Reiner AP, Schwartz SM, Frank MB, Longstreth WT, Jr., Hindorff LA, Teramura G, et al. Polymorphisms of coagulation factor XIII subunit A and risk of nonfatal hemorrhagic stroke in young white women. Stroke. 2001; 32(11): 2580-6[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments